🇺🇸 Garamycin in United States

FDA authorised Garamycin on 15 March 1966

Marketing authorisations

FDA — authorised 15 March 1966

  • Application: ANDA060462
  • Marketing authorisation holder: SCHERING
  • Local brand name: GARAMYCIN
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 15 March 1966

  • Application: ANDA060463
  • Marketing authorisation holder: SCHERING
  • Local brand name: GARAMYCIN
  • Indication: OINTMENT — TOPICAL
  • Status: approved

Read official source →

FDA — authorised 19 June 1970

  • Marketing authorisation holder: SCHERING
  • Status: approved

FDA — authorised 19 June 1970

  • Application: NDA050039
  • Marketing authorisation holder: SCHERING
  • Local brand name: GARAMYCIN
  • Indication: SOLUTION/DROPS — OPHTHALMIC
  • Status: approved

Read official source →

FDA — authorised 25 November 1970

  • Application: NDA050425
  • Marketing authorisation holder: SCHERING
  • Local brand name: GARAMYCIN
  • Indication: OINTMENT — OPHTHALMIC
  • Status: approved

Read official source →

FDA — authorised 3 March 1981

  • Application: ANDA061716
  • Marketing authorisation holder: SCHERING
  • Local brand name: GARAMYCIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 4 October 1993

  • Application: ANDA062420
  • Marketing authorisation holder: HOSPIRA
  • Indication: Manufacturing (CMC)
  • Status: approved

Read official source →

FDA — authorised 29 April 1994

  • Application: ANDA064056
  • Marketing authorisation holder: COSETTE
  • Status: approved

Read official source →

FDA — authorised 29 April 1994

  • Application: ANDA064054
  • Marketing authorisation holder: COSETTE
  • Status: approved

Read official source →

FDA — authorised 27 June 2000

  • Application: ANDA064048
  • Marketing authorisation holder: BAUSCH AND LOMB
  • Indication: Manufacturing (CMC)
  • Status: approved

Read official source →

FDA — authorised 11 December 2015

  • Application: ANDA062373
  • Marketing authorisation holder: BAXTER HLTHCARE
  • Indication: Labeling
  • Status: approved

Read official source →

Garamycin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Garamycin approved in United States?

Yes. FDA authorised it on 15 March 1966; FDA authorised it on 15 March 1966; FDA authorised it on 19 June 1970.

Who is the marketing authorisation holder for Garamycin in United States?

SCHERING holds the US marketing authorisation.